Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company specializing in nitric oxide therapies, announced it will release its financial results for the quarter ended June 30, 2026, on August 13, 2026. The company will hold a conference call and webcast to discuss the results.